John Sundy Net Worth & Insider Trades

John Sundy - Chief Medical Officer, Pandion Therapeutics, Inc

As of July 21, 2020

What is John Sundy's Net Worth?

The current estimated net worth of Pandion Therapeutics, Inc's Chief Medical Officer, John Sundy, is estimated to be about $2.08M . John Sundy owns about 115,826 units of Pandion Therapeutics, Inc common stock. Recently at Pandion Therapeutics, Inc, John Sundy has sold an estimated value of $0 worth.

What is John Sundy's Past Insider Trading?

John Sundy's largest purchase order was 2,000 units , worth over $36K on July 21, 2020. In total, John Sundy has made about 1 transaction recently at Pandion Therapeutics, Inc. John Sundy usually trades in July, with the busiest year in 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

John Sundy

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is John Sundy's' Mailing Address?

  • Mailing address is C/o Pandion Therapeutics, Inc. 134 Coolidge Ave., 2nd Floor Watertown MA 02472 MA

What are Pandion Therapeutics, Inc's Past Insider Trades?

Pandion Therapeutics, Inc's most recent insider trade came on November 23, 2020 by Daniel J Becker who bought 197,716 units worth $2.99M . In the last 4 months, insiders at Pandion Therapeutics, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in July, with the busiest year in 2020. The most active traders at the company are Daniel J Becker, Director,  Mitchell Mutz, Director,  and Aaron Davis .

Pandion Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...